| Total Voting Rights | 02-Jan-2026 | 07:00 | RNS |
| Block Listing Return | 02-Jan-2026 | 07:00 | RNS |
| Block Listing Return | 02-Jan-2026 | 07:00 | RNS |
| Total Voting Rights | 02-Jan-2026 | 07:00 | RNS |
| PDMR Dealing | 08-Dec-2025 | 15:15 | RNS |
| Total Voting Rights | 01-Dec-2025 | 07:00 | RNS |
| Holding(s) in Company | 03-Nov-2025 | 16:55 | RNS |
| Total Voting Rights | 03-Nov-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 20-Oct-2025 | 17:54 | RNS |
| Director/PDMR Shareholding | 20-Oct-2025 | 17:13 | RNS |
| Board Change | 20-Oct-2025 | 10:17 | RNS |
| Director/PDMR Shareholding | 16-Oct-2025 | 07:00 | RNS |
| Acquisition of US viral vector facility | 07-Oct-2025 | 07:00 | RNS |
| Total Voting Rights | 01-Oct-2025 | 07:00 | RNS |
| Interim Results for 6 months ended 30 June 2025 | 23-Sep-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 681.00p |
| Change Today | 18.00p |
| % Change | 2.71 % |
| 52 Week High | 697.00 |
| 52 Week Low | 232.50 |
| Volume | 170,798 |
| Shares Issued | 120.75m |
| Market Cap | £822.33m |
| Beta | 1.79 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| No dividends found |
| Time | Volume / Share Price |
| 13:18 | 31 @ 681.00p |
| 13:18 | 242 @ 682.00p |
| 13:18 | 109 @ 682.00p |
| 13:18 | 271 @ 683.00p |
| 13:18 | 90 @ 683.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research